RMB Capital Management »

Crispr Therapeutics shares owned by RMB Capital Management

Quarter-by-quarter ownership of Crispr Therapeutics (CRSP) shares owned by RMB Capital Management from 13F filings

Historical chart of RMB Capital Management investment in Crispr Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Crispr Therapeutics held by RMB Capital Management consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Crispr Therapeutics by RMB Capital Management

Quarter filed Position value Share count Share price at filing
2023-12-31 $2.0M 32k 62.60
2023-09-30 $1.4M 31k 45.39
2023-06-30 $1.8M 32k 56.14
2023-03-31 $1.4M 32k 45.23
2022-12-31 $1.1M 27k 40.65
2022-09-30 $2.4M 36k 65.36
2022-06-30 $2.2M 36k 60.78
2022-03-31 $2.5M 40k 62.76
2021-12-31 $2.5M 33k 75.79
2021-09-30 $2.5M 22k 111.92
2021-06-30 $3.6M 22k 161.89
2021-03-31 $1.4M 11k 121.83
2020-12-31 $444k 2.9k 153.10
2020-09-30 $243k 2.9k 83.79
2020-06-30 $213k 2.9k 73.45